{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T09:51:20Z","timestamp":1722937880524},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00347-021-01505-2","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T23:55:35Z","timestamp":1633478135000},"page":"1216-1221","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Struktur\/Funktion\/Behandlung beim Glaukom: Fortschritt in den letzten 10\u00a0Jahren"],"prefix":"10.1007","volume":"118","author":[{"given":"Frances","family":"Meier-Gibbons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"T\u00f6teberg-Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"issue":"5","key":"1505_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archopht.117.5.573","volume":"117","author":"MO Gordon","year":"1999","unstructured":"Gordon\u00a0MO, Kass\u00a0MA (1999) The ocular hypertension treatment study: design and baseline description of the participants. Arch Ophthalmol 117(5):573\u2013583","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1505_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon\u00a0MO, Beiser\u00a0JA, Brandt\u00a0JD et al (2002) The ocular hypertension treatment study: base-line factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):714\u2013720","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1505_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass\u00a0MA, Heuer\u00a0DK, Higginbotham\u00a0EJ et al (2002) The ocular hypertension treatment study\u2014a\u00a0randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701\u2013713","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1505_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archophthalmol.2010.20","volume":"128","author":"MA Kass","year":"2010","unstructured":"Kass\u00a0MA, Gordon\u00a0MO, Gao\u00a0F et\u00a0al (2010) Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol 128(3):276\u2013287","journal-title":"Arch Ophthalmol"},{"key":"1505_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.0341","author":"MA Kass","year":"2021","unstructured":"Kass\u00a0MA, Heuer\u00a0DK, Higginbotham\u00a0EJ, Parrish\u00a0RK, Khanna\u00a0CL, Brandt\u00a0JD, Soltau\u00a0JB, Johnson\u00a0CA, Keltner\u00a0JL, Huecker\u00a0JB, Wilson\u00a0BS, Liu\u00a0L, Miller\u00a0JP, Quigley\u00a0HA, Gordon\u00a0MO, Ocular Hypertension Study Group (2021) Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.0341","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"1505_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.ophtha.2010.03.044","volume":"117","author":"RN Weinreb","year":"2010","unstructured":"Weinreb\u00a0RN, Zangwill\u00a0LM, Jain\u00a0S et\u00a0al (2010) Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Ophthalmology 117(9):1674\u20131683","journal-title":"Ophthalmology"},{"issue":"9","key":"1505_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1001\/archopht.123.9.1188","volume":"123","author":"LM Zangwill","year":"2005","unstructured":"Zangwill\u00a0LM, Weinreb\u00a0RN, Beiser\u00a0JA et al (2005) Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol 123(9):1188\u20131197","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1505_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajo.2003.08.031","volume":"137","author":"LM Zangwill","year":"2004","unstructured":"Zangwill\u00a0LM, Weinreb\u00a0RN, Berry\u00a0CC et\u00a0al (2004) The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol 137(2):219\u2013227","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1505_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1001\/archopht.122.1.22","volume":"122","author":"LM Zangwill","year":"2004","unstructured":"Zangwill\u00a0LM, Weinreb\u00a0RN, Berry\u00a0CC et\u00a0al (2004) Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol 122(1):22\u201328","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"1505_CR10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.ophtha.2006.06.022","volume":"113","author":"DL Budenz","year":"2006","unstructured":"Budenz\u00a0DL, Anderson\u00a0DR, Feuer\u00a0WJ et\u00a0al (2006) Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study. Ophthalmology 113(12):2137\u20132143","journal-title":"Ophthalmology"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ajo.2016.10.023","volume":"174","author":"DL Budenz","year":"2017","unstructured":"Budenz\u00a0DL, Huecker\u00a0JB, Gedde\u00a0SJ, Gordon\u00a0M, Kass\u00a0M, Ocular Hypertension Treatment Study Group. (2017) Thirteen-year follow-up of optic disc hemorrhages in the ocular hypertension treatment study. Am J Ophthalmol 174:126\u2013133. https:\/\/doi.org\/10.1016\/j.ajo.2016.10.023","journal-title":"Am J Ophthalmol"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2020.04.013","volume":"217","author":"X Cousins","year":"2020","unstructured":"Cousins\u00a0X, Chou\u00a0JC, Shen\u00a0LQ, Gordon\u00a0MO, Kass\u00a0MA, Ritch\u00a0R, Pasquale\u00a0LR (2020) Densitometric profiles of optic disc hemorrhages in the ocular hypertension treatment study. Am J Ophthalmol 217:10\u201319","journal-title":"Am J Ophthalmol"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0161-6420(01)00760-6","volume":"108","author":"JD Brandt","year":"2001","unstructured":"Brandt\u00a0JD, Beiser\u00a0JA, Kass\u00a0MA, Gordon MO and the Ocular Hypertension Treatment Study (OHTS) Group (2001) Central corneal thickness in the ocular hypertension treatment study (OHTS). Ophthalmology 108:1779\u20131788","journal-title":"Ophthalmology"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ophtha.2011.03.018","volume":"119","author":"JD Brandt","year":"2012","unstructured":"Brandt\u00a0JD, Gordon\u00a0MO, Gao\u00a0F, Beiser\u00a0JA, Miller\u00a0JP, Kass\u00a0MA, the Ocular Hypertension Treatment Study (OHTS) Group (2012) Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology 119:437\u2013442","journal-title":"Ophthalmology"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ogla.2020.04.012","volume":"3","author":"A Thakur","year":"2020","unstructured":"Thakur\u00a0A, Goldbaum\u00a0M, Yousefi\u00a0S (2020) Predicting glaucoma before onset using deep learning. Ophthalmol Glaucoma 3:262\u2013268","journal-title":"Ophthalmol Glaucoma"},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0161-6420(99)90147-1","volume":"106","author":"DC Musch","year":"1999","unstructured":"Musch\u00a0DC, Lichter\u00a0PR, Guire\u00a0KE, CIGTS Study Group et\u00a0al (1999) The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106:653\u2013662","journal-title":"Ophthalmology"},{"key":"1505_CR17","first-page":"26","volume":"1","author":"ME Sloane","year":"1992","unstructured":"Sloane\u00a0ME, Ball\u00a0K, Owsley\u00a0C et\u00a0al (1992) The visual activities questionnaire: developing an instrument for assessing problems in everyday visual tasks. Tech Dig Noninvas Assess Vis Sys 1:26\u201329","journal-title":"Tech Dig Noninvas Assess Vis Sys"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","volume":"19","author":"M Bergner","year":"1981","unstructured":"Bergner\u00a0M, Bobbitt\u00a0RA, Carter\u00a0WB et\u00a0al (1981) The sickness impact profile: development and final revision of a\u00a0health status measure. Med Care 19:787\u2013805","journal-title":"Med Care"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter\u00a0PR, Musch\u00a0DC, Gillespie\u00a0BW, CIGTS Study Group et\u00a0al (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943\u20131953","journal-title":"Ophthalmology"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","volume":"116","author":"DC Musch","year":"2009","unstructured":"Musch\u00a0DC, Gillespie\u00a0BW, Lichter\u00a0PR, CIGTS Study Group et\u00a0al (2009) Visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology 116:200\u2013207","journal-title":"Ophthalmology"},{"issue":"10","key":"1505_CR21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jamaophthalmol.2018.3274","volume":"136","author":"LM Niziol","year":"2018","unstructured":"Niziol\u00a0LM, Gillespie\u00a0BW, Musch\u00a0DC (2018) Association of felloweye with study eye disease trajectories and need for felloweye treatment in collaborative initial glaucoma treatment study (CIGTS) participants. JAMA Ophthalmol 136(10):1149\u20131156","journal-title":"JAMA Ophthalmol"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ajo.2012.10.017","volume":"155","author":"S Zahid","year":"2013","unstructured":"Zahid\u00a0S, Musch\u00a0DC, Niziol\u00a0LM, Lichter\u00a0PR (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 155:674\u2013680","journal-title":"Am J Ophthalmol"},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2016.03.016","volume":"166","author":"D Gupta","year":"2016","unstructured":"Gupta\u00a0D, Musch\u00a0DC, Niziol\u00a0LM, Chen\u00a0PP (2016) Refusal of trabeculectomy for the fellow eye in collaborative initial glaucoma treatment study (CIGTS) participants. Am J Ophthalmol 166:1\u20137","journal-title":"Am J Ophthalmol"},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2018.09.015","volume":"197","author":"DC Musch","year":"2019","unstructured":"Musch\u00a0DC, Niziol\u00a0LM, Janz\u00a0NK, Gillespie\u00a0BW (2019) Trends in and predictors of depression among participants in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 197:128\u2013135","journal-title":"Am J Ophthalmol"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey\u00a0PA, NIziol\u00a0LM, Gillespie\u00a0BW, Janz\u00a0NK, Lichter\u00a0PR, Musch\u00a0DC (2020) The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology 127:477\u2013483","journal-title":"Ophthalmology"},{"issue":"1","key":"1505_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ophtha.2012.07.028","volume":"120","author":"DF Garway-Heath","year":"2013","unstructured":"Garway-Heath\u00a0DF, Lascaratos\u00a0G, Bunce\u00a0C, Crabb\u00a0DP, Russell\u00a0RA, Shah\u00a0A, United Kingdom Glaucoma Treatment Study Investigators (2013) The United Kingdom glaucoma treatment study: a\u00a0multicenter, randomized, placebo-controlled clinical trial: design and methodology. Ophthalmology 120(1):68\u201376. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.028","journal-title":"Ophthalmology"},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2018.09.034","volume":"126","author":"L Jones","year":"2019","unstructured":"Jones\u00a0L, Garway-Heath\u00a0DF, Azuaro-Blanco\u00a0A, Crabb\u00a0DP (2019) Are patient self-reported outcome measures sensitive enough to be used as\u00a0end\u00a0points in clinical trials?: Evidence from the united kingdom glaucoma treatment study. Ophthalmology 126:682\u2013689","journal-title":"Ophthalmology"},{"issue":"12","key":"1505_CR28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.ophtha.2020.06.009","volume":"127","author":"P Founti","year":"2020","unstructured":"Founti\u00a0P, Bunce\u00a0C, Khawaja\u00a0AP, Dor\u00e9\u00a0CJ, Mohamed-Noriega\u00a0J, Garway-Heath\u00a0DF, United Kingdom Glaucoma Treatment Study Group (2020) Risk factors for visual field deterioration in the United Kingdom glaucoma treatment study. Ophthalmology 127(12):1642\u20131651. https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.009","journal-title":"Ophthalmology"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3310\/hta20080","volume":"20","author":"A Azuara-Blanco","year":"2016","unstructured":"Azuara-Blanco\u00a0A, Banister\u00a0K, Boachie\u00a0C, McMeekin\u00a0P, Gray\u00a0J, Burr\u00a0J, Bourne\u00a0R, Garway-Heath\u00a0D, Batterbury\u00a0M, Hernandez\u00a0R, McPherson\u00a0G, Ramsay\u00a0C, Cook\u00a0J (2016) Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study). Health Technol Assess 20:8","journal-title":"Health Technol Assess"},{"issue":"5","key":"1505_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ophtha.2016.01.041","volume":"123","author":"K Banister","year":"2016","unstructured":"Banister\u00a0K, Boachie\u00a0C, Bourne\u00a0R, Cook\u00a0JA, Burr\u00a0J, Ramsay\u00a0C, Garway-Heath\u00a0D, Gray\u00a0J, McKeekin\u00a0P, Hernandez\u00a0R, Azuara-Blanco\u00a0A (2016) Can automated imaging with HRT for disc and GDx-ECC and spectralis OCT for retinal nerve fiber layer analysis aid glaucoma detection? Ophthalmology 123(5):930\u2013938","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01505-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:07:53Z","timestamp":1638788873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01505-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01505-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"1 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Meier-Gibbons und M.\u00a0T\u00f6teberg-Harms geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}